ACCREDITATION STATEMENT
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.The Endocrine Society has achieved Accreditation with Commendation.
The Endocrine Society designates this enduring material for a maximum of 18.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
STATEMENT OF INDEPENDENCE
As a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education, The Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of The Endocrine Society's Trainee and Development Core Committee (TCDCC). The commercial supporters of this activity have no influence over the selection of the faculty or specific presentations.DISCLAIMER
The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of The Endocrine Society.LEARNING OBJECTIVES
Upon completion of this educational activity, learners will be better able to:
- Discuss state-of-the-art research in endocrinology
- Demonstrate updated knowledge of the diagnosis and treatment of diabetes, osteoporosis, pediatric, thyroid, and reproductive endocrine disorders
- Employ enhanced skills and practice management techniques to improve patient care
- Employ new perspectives in career paths to make important decisions about their future training, research and practice of medicine
TARGET AUDIENCE
This continuing medical education activity should be of substantial interest to basic research and clinical fellows engaged in advancing endocrine research.DISCLOSURE POLICY
The faculty, committee members, and staff involved in planning this CME activity are required to disclose to learners any relevant financial relationship(s) that have occurred within the last 12 months with any commercial interest(s) whose products or services are discussed in the CME content. Such relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent faculty with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments. It remains for learners to determine whether financial interests or relationships may influence the educational activity with regard to exposition or conclusion.The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported relevant financial relationships:
- John Bilezikian, MD, has been a consultant for GlaxoSmithKline, NPS, and as a speaker for Novartis, Amgen, and Lilly
- William Chin, MD, has been a consultant for Johnson & Johnson and Karo Bio, and is a former employee of Eli Lilly & Co
- Gary Hammer, MD, PhD, has been a consultant for OSI and Orphagen
- Jon Nakamoto, MD, PhD, is employed by and has stock in Quest Diagnostics Nichols Institute
- Sonali Nayak is employed by EMD Millipore
- Michael Rosenblatt is employed by Merck & Co, Inc.
- Stuart Weinzimer, MD, PhD, has been a consultant in an advisory role for Medtronic, Novo Nordisk, Animas, Becton-Dickinson, and as a speaker for Eli Lilly & Co.
The following faculty reported no relevant financial relationships:
- Rhonda Bentley-Lewis, MBA, MD, MMSC
- Sally Camper, PhD
- Arthur Gutierrez-Hartmann, MD
- Ursula Kaiser, BSc, MD
- Alison Kim, PhD
- Elliot Levy, MD, FACP
- Joseph Majzoub, MD
- Saul Malozowski, MD, PhD, MBA
- Berenice Mendonca, MD
- Vivek Murthy, MD, MBA
- John Nilson, PhD
- Michel Sanders, PhD
- Robert Millar, PhD
- William Schrader, PhD
- Andrew Sinclair, PhD
- Marc Tetel, PhD
- Carmen Williams, MD, PhD
The following 2011 Endocrine Trainee Day Planning Committee members who planned and/or reviewed content for this activity reported relevant financial relationships:
- None
The following 2011 Endocrine Trainee Day Planning Committee members who planned and/or reviewed content for this activity reported no relevant financial relationships:
- Robert Dearth, PhD
- Michele La Merrill, PhD
- Mark Lawson, PhD
- Michael McDermott, MD
- Natasha Mott, BS
- Joanna Spencer, PhD
- Kristen Vella, PhD
- Maria Yialamas, MD
Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.
CONFLICT OF INTEREST STATEMENT
The scientific content of this activity was developed by The Endocrine Society's Trainee and Career Development Core Committee (TCDCC), independent of grant support and in accordance with the ACCME's Essential Areas and Elements, inducing the Standards for Commercial Support. The commercial supporters of this meeting have no influence over topics or speakers.POLICY ON UNLABELED/OFF-LABEL USAGE
The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such "off-label" use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.PRIVACY & CONFIDENTIALITY STATEMENT
The Endocrine Society will record learner's personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
This activity is supported by educational grant(s) from Amgen, Endo Pharmaceuticals, Genzyme, Merck & Co, Inc., and Pfizer, Inc.METHOD OF PARTICIPATION
The estimated time to complete this activity, including review of material, is 18.75 hour(s).This enduring material is presented in an online/computer-based format. System requirements include:
For Windows, Firefox 1.5 or Internet Explorer 6.0 with Flash 8 or better installed.
For Macintosh OS X, Safari 2.0 or Firefox 1.5 with Flash 8 or better installed.To receive a maximum of 18.75 AMA PRA Category 1 Credit(s)™ participants should:
- Select a session and listen to the audio and/or view the slides.
- Complete the evaluation provided at the end of the session and click on "submit" to add the session to the learner's transcript. The transcript will appear and the learner will have the option of printing a CME certificate then or at a later time, after viewing multiple sessions.
- Select additional sessions and proceed as directed above, to accumulate credits for participating in multiple sessions.
- Credits awarded correspond to the length of time for each session, which varies from 0.25 to 1.0 hours
LAST REVIEW DATE: June, 2011.
ACTIVITY RELEASE DATE: June, 2011.
ACTIVITY EXPIRATION DATE: June, 2012.For technical assistance or information, please contact 1-888-711-1138 ext.241 (Monday - Friday 9:00 AM to 5:00 PM EST) or E-mail: multiviewMediaSupport@multiview.com.
For questions regarding CME content or obtaining CME credit for this activity, please contact The Endocrine Society at 301.941.0200 or amcelvaine@endo-society.org.